Cancer cell-derived fibroblast growth factor 2 (FGF2) can facilitate TAM survival and migration through AKT/ERK signaling, activated by neural cell adhesion molecule 1-enhanced classical FGF receptor 1 (FGFR1) and intracellular FGF2/FGFR1 signaling. The gene discussed is AKT1; the disease is cancer.